Form 4: Rise Gold Director Boosts Stake with New Options
Insider Transaction Report
Rise Gold Corp. Director Thomas I. Vehrs acquired 100,000 stock options and holds a total of 512,775 options and 25,000 common shares.
Summary
- Thomas I. Vehrs, a Director of Rise Gold Corp. (RYES), filed a Form 4 disclosing changes in beneficial ownership.
- On October 30, 2025, Vehrs acquired 100,000 stock options with an exercise price of $0.25 per share, which become exercisable on the same date and expire on October 30, 2030.
- Following this transaction, Vehrs directly beneficially owns 25,000 shares of common stock.
- Vehrs also directly beneficially owns a total of 512,775 derivative securities (stock options) across multiple grants with various exercise prices and expiration dates.
Sentiment
Score: 7
Explanation: A director increasing their potential equity stake through option grants typically signals confidence in the company's future performance and aligns management interests with shareholders, which is generally a positive indicator.
Positives
- Director Thomas I. Vehrs acquired 100,000 new stock options, indicating continued alignment of interests with shareholders.
- The acquisition of options at an exercise price of $0.25 suggests a belief in future stock price appreciation above this level.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Grant of 100,000 stock options to Director Thomas I. Vehrs by Rise Gold Corp. on October 30, 2025.
Stakeholder Impact
- Shareholders may view the director's increased equity stake as a positive signal of management confidence and alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 02/07/2022 | Date 100,000 stock options with an exercise price of $0.65 became exercisable. |
| 02/21/2023 | Date 105,000 stock options with an exercise price of $0.53 became exercisable. |
| 09/22/2023 | Date 25,000 stock options with an exercise price of $0.26 became exercisable. |
| 12/12/2023 | Date 47,775 stock options with an exercise price of $0.25 became exercisable. |
| 05/01/2024 | Date 15,000 stock options with an exercise price of $0.17 became exercisable. |
| 03/25/2025 | Date 60,000 stock options with an exercise price of $0.1 become exercisable. |
| 05/22/2025 | Date 60,000 stock options with an exercise price of $0.1 become exercisable. |
| 10/30/2025 | Earliest transaction date; acquisition of 100,000 stock options with an exercise price of $0.25, becoming exercisable on this date. |
| 11/03/2025 | Signature date of the reporting person. |
| 02/07/2027 | Expiration date for 100,000 stock options with an exercise price of $0.65. |
| 02/21/2028 | Expiration date for 105,000 stock options with an exercise price of $0.53. |
| 09/22/2028 | Expiration date for 25,000 stock options with an exercise price of $0.26. |
| 12/12/2028 | Expiration date for 47,775 stock options with an exercise price of $0.25. |
| 05/01/2029 | Expiration date for 15,000 stock options with an exercise price of $0.17. |
| 03/25/2030 | Expiration date for 60,000 stock options with an exercise price of $0.1. |
| 05/22/2030 | Expiration date for 60,000 stock options with an exercise price of $0.1. |
| 10/30/2030 | Expiration date for 100,000 stock options with an exercise price of $0.25. |
Recommendation
holdThe acquisition of stock options by a director is a positive signal, indicating management's belief in future growth. However, without broader financial context or operational updates, a 'hold' recommendation is prudent, acknowledging the positive insider action while awaiting more comprehensive company information.
Keywords
Rise Gold Corp, RYES, Form 4, insider transaction, stock options, beneficial ownership, director, equity, executive compensation, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.